Related Experiment Videos
Slow release theophylline in preschool asthmatics
Insights
Slow-release theophylline (Slo-phyllin) offers benefits for wheezing preschool children with asthma. While symptom scores showed no change, active treatment improved other indicators, suggesting its value in managing childhood asthma.
Area of Science:
- Pediatric Pulmonology
- Clinical Pharmacology
Background:
- Asthma is a common chronic respiratory disease in young children.
- Wheezing in preschool children presents diagnostic and management challenges.
- Theophylline has been used for asthma, but its efficacy in very young children requires evaluation.
Purpose of the Study:
- To evaluate the efficacy of slow-release theophylline (Slo-phyllin) in preschool children with asthma.
- To compare active treatment with placebo using a double-blind crossover design.
- To assess the utility of symptom scores as a measure of clinical improvement in this age group.
Main Methods:
- A double-blind, placebo-controlled crossover trial was conducted.
- Participants were children aged up to 4 years diagnosed with asthma.
- Patients received either slow-release theophylline or a placebo in a randomized sequence.
Main Results:
- No significant difference was observed in overall symptom scores between the active treatment and placebo groups.
- However, other clinical indicators favored the active theophylline treatment.
- The study highlights potential benefits beyond standard symptom scoring.
Conclusions:
- Slow-release theophylline (Slo-phyllin) demonstrates benefit in managing wheezing preschool children with asthma.
- The preparation is a valuable option for this patient population.
- The study discusses the limitations of symptom scores in assessing clinical improvement in young asthmatic children.
Abstract:
A double blind crossover trial with active or placebo slow release theophylline (Slo-phyllin) in children with asthma aged up to 4 years is described. Although no difference in symptom scores was shown, other differences in favour of active treatment were noted. We conclude that this preparation is of benefit in the management of the wheezing preschool child. The value of symptom scores as an index of clinical improvement is discussed.